logo
Covid was bad for our brains (even for those who didn't catch it)

Covid was bad for our brains (even for those who didn't catch it)

Times3 days ago
The Covid-19 pandemic was 'detrimental' to brain health, even for those who never contracted the virus, a study has suggested.
Academics say that the strain of the pandemic on people's lives may have aged our brains prematurely.
The team, from the University of Nottingham, found that brain ageing during the pandemic was 'more ­pronounced' among men, older people and those from deprived ­backgrounds.
• Is your holiday making you ill?
Dr Ali-Reza Mohammadi-Nejad, who led the study, said: 'What ­surprised me most was that even people who hadn't had Covid showed significant increases in brain ageing rates. It really shows how much the ­experience of the pandemic itself, everything from isolation to ­uncertainty, may have affected our brain health.'
The team trained a brain-ageing model on more than 15,000 healthy people, then applied the model to 1,000 people taking part in the UK Biobank study, a long-term piece of research tracking the health of British adults. Half of this group were assessed before the global pandemic, and half were assessed before and after.
The research, published in Nature Communications, found that those who had lived through the crisis had a '5.5 month higher deviation of brain age gap' compared with the people who were only assessed before the ­pandemic. 'We found that the Covid-19 pandemic was detrimental to brain health and induced accelerated brain ageing … regardless of Sars-CoV-2 ­infection,' the experts said.
The team also assessed cognitive ­performance by looking at tests taken at the time of the scans. Those infected with the virus were found to perform worse on cognitive tests when they were assessed before and after the pandemic.
• Optimists all on same wavelength, but no two pessimists are alike
Professor Dorothee Auer, a senior author of the study, added: 'This study reminds us that brain health is shaped not only by illness, but by our everyday environment. The pandemic put a strain on people's lives, especially those already facing disadvantage. We can't yet test whether the changes we saw will reverse, but it's ­certainly possible, and that's an encouraging thought.'
Professor Masud Husain, from the University of Oxford and who is not ­affiliated with the research, urged 'caution' when interpreting the results. He said: 'The brain age difference between the two groups (as indexed by brain scanning) was on average only five months, and difference in cognitive performance between groups was only on the total time taken to complete one of the tests.
'Is this really going to make a significant difference in everyday life? The time between scans was much shorter in the people scanned before and after the pandemic, compared to those who had both scans before the pandemic. We therefore don't know if brain ageing would have recovered if more time elapsed.'
Previous research has found that people who had Covid performed less well in cognitive tests, especially executive function. Scientists from Imperial College London found that those who had had Covid scored about three IQ points lower than those who had not been ­infected. Those who had been in ­intensive care scored nine points lower, and those who suffer from long Covid scored about six points lower than uninfected individuals.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UK-India trade deal sparks fears over access to cheap medicines for millions
UK-India trade deal sparks fears over access to cheap medicines for millions

ITV News

time14 minutes ago

  • ITV News

UK-India trade deal sparks fears over access to cheap medicines for millions

A newly signed trade agreement between India and the UK has triggered concerns that millions of poor Indians may lose access to affordable life-saving medicines. Civil society groups and health experts say the UK-India Free Trade Agreement (FTA), finalised between two countries, tilts the balance in favour of multinational pharmaceutical corporations and threatens to erode long-standing protections that have allowed India to produce low-cost generic drugs. 'This is not just about trade. It's about whether a person living on ₹200 (£2) a day can afford cancer treatment or survive tuberculosis,' said Jyotsna Singh, co-convenor of the Working Group on Access to Medicines and Treatments. At the heart of the controversy are the agreement's intellectual property (IP) provisions, which activists say may restrict the Indian government's ability to issue compulsory licences—legal tools that allow domestic companies to manufacture patented drugs at reduced prices during public health emergencies. India used this provision in 2012 to dramatically cut the price of sorafenib, a cancer drug sold by Bayer under the brand Nexavar. Generic versions slashed the monthly cost by nearly 97%, from ₹2.8 lakh (£2,600) to around ₹8,800 (£80), making it affordable to thousands. 'By discouraging compulsory licensing and promoting voluntary licences, the deal hands over control of access to medicines to the market,' said Prof Biswajit Dhar, a trade expert and former professor at New Delhi's Jawaharlal Nehru University. 'Voluntary licences often come with strings attached and don't bring the same price reductions.' Weakening India's Patent Safeguards Under the FTA, companies will no longer need to report annually how their patents are being 'worked'—or used—in India. Instead, disclosures can be made every three years, and some information can be kept confidential. Activists say this undermines transparency and makes it harder to prove that a drug isn't available to the public, a key step in applying for a compulsory licence. There are also concerns the deal could open the door to 'evergreening'—a tactic in which companies make minor changes to existing drugs and claim new patents. Indian law currently limits this practice under Section 3(d) of the Patents Act, but experts warn the FTA's emphasis on 'harmonisation' of IP standards with Western countries could override such protections. 'This is effectively a backdoor entry for TRIPS-plus provisions,' said K.M. Gopakumar, co-convenor of the Working Group. 'It would push India to grant unnecessary patents, prolonging monopolies and delaying cheaper alternatives.' The Indian pharmaceutical industry supplies more than 60% of global vaccines and a significant share of affordable generics to low- and middle-income countries. Critics say the FTA may limit this capacity and ultimately have consequences well beyond India's borders. Government response The Indian government has promoted the FTA as a landmark deal that will boost exports and attract UK investment in manufacturing, services, and digital trade. Officials insist that India has preserved its ability to protect public health. But rights groups remain unconvinced. 'You cannot negotiate away access to life-saving drugs in the name of free trade,' said Gargeya Telakapalli, a public health campaigner based in Hyderabad. 'The poorest Indians—those with cancer, HIV, diabetes, or TB—are being quietly sacrificed.' Broader implications The deal follows a similar agreement India signed last year with the European Free Trade Association (EFTA), which also faced criticism for diluting IP safeguards. Observers say the trend may reflect a shift in India's trade policy as it seeks closer ties with Western economies. But for many in India's healthcare and legal communities, the question remains: how much access to medicine is the country willing to give up for a better trade balance? From Westminster to Washington DC - our political experts are across all the latest key talking points. Listen to the latest episode below...

Rare Angel shark filmed in Cardigan Bay on underwater camera
Rare Angel shark filmed in Cardigan Bay on underwater camera

BBC News

time14 minutes ago

  • BBC News

Rare Angel shark filmed in Cardigan Bay on underwater camera

One of the world's rarest sharks has been caught on camera in Cardigan Bay for the first time in four Perry, a marine conservation and research manager with the Wildlife Trust of South and West Wales, said she was "thrilled" by the "rare and exciting encounter" with the angel shark which lives and hunts on the endangered, the species was filmed on an underwater camera being used to study a group of bottlenose dolphins that make their home off the Welsh angel shark was common across the east Atlantic and Mediterranean seas but has declined because of a number of threats, including habitat disturbance and accidental fishing catch. A juvenile angel shark was caught on camera in September 2021 in Cardigan Perry said the latest sighting "comes at a crucial time, as the Senedd and UK government discuss a ban on bottom trawling in marine protected areas". "These findings highlight the urgent need to protect these fragile habitats from damaging activities like bottom trawling," she sharks, known as a "flat shark", spends much of the time camouflaged in the sediments on the seabed, where they lie in wait for 2019, experts said sightings suggested Wales could be a key habitat for the angel shark which has had a stronghold around the Canary Islands.

Health warning over counterfeit vodka made with medical-grade alcohol
Health warning over counterfeit vodka made with medical-grade alcohol

Metro

time44 minutes ago

  • Metro

Health warning over counterfeit vodka made with medical-grade alcohol

Health officials in Scotland have warned fans of Glen's vodka to keep an eye out for fake half bottles containing medical disinfectant. Scammers have hijacked the popular brand to sell counterfeit products containing the chemical isopropyl, which is typically used in hospital settings or in hand sanitiser. Food Standards Scotland (FSS) say the fake booze will smell and taste 'very different' to the Glen's product people recognise. Even small amounts of isopropyl can result in abdominal pain, vomiting, dizziness and headaches, they warned. Severe cases can leave drinkers in a coma or even dead. Genuine bottles of Glen's have a laser-etched code between the rear label and the base of the bottle which the fake bottles will not. More Trending Anyone concerned they might have drunk the counterfeit vodka, and who is experiencing symptoms, is urged to contact NHS 24 on 111 immediately. Glen's, one of the cheaper brands of vodka on the market, is a popular target for scammers. FSS has previously sent investigators to seize dozens of bottles of fake spirit using the same label from a shop in Coatbridge, Lanarkshire. And in September last year, the UK-wide Food Standards Agency sent out a warning about another fraud involving isopropyl alcohol in Glen's bottles. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: The one drink you should never order from a restaurant wine list MORE: How a generation-bending TikTok campaign saved a local boozer MORE: Forget about Prosecco — drink this £6.97 sparkling wine from Asda instead

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store